Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med 163: 2433-2445

Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Archives of Internal Medicine (Impact Factor: 17.33). 12/2003; 163(20):2433-45. DOI: 10.1001/archinte.163.20.2433
Source: PubMed

ABSTRACT Because depression and painful symptoms commonly occur together, we conducted a literature review to determine the prevalence of both conditions and the effects of comorbidity on diagnosis, clinical outcomes, and treatment. The prevalences of pain in depressed cohorts and depression in pain cohorts are higher than when these conditions are individually examined. The presence of pain negatively affects the recognition and treatment of depression. When pain is moderate to severe, impairs function, and/or is refractory to treatment, it is associated with more depressive symptoms and worse depression outcomes (eg, lower quality of life, decreased work function, and increased health care utilization). Similarly, depression in patients with pain is associated with more pain complaints and greater impairment. Depression and pain share biological pathways and neurotransmitters, which has implications for the treatment of both concurrently. A model that incorporates assessment and treatment of depression and pain simultaneously is necessary for improved outcomes.

Download full-text


Available from: Rebecca L Robinson, Dec 19, 2013
160 Reads
  • Source
    • "The coexistence of pain and depression significantly increases the risk of negative clinical outcomes. Moreover, shared biological pathways have been described between the two (e.g., dysregulation of serotonin and norepinephrine associated with depression also influences the transmission of nociceptive signals) (Bair MJ et al., 2003). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Frailty has been identified as a promising condition for distinguishing different degrees of vulnerability among older persons. Several operational definitions have proposed fatigue as one of the features characterizing the frailty syndrome. However, such a subjective symptom is still not yet sufficiently explored and understood. Fatigue is a common and distressing self-reported symptom perceived by the person while performing usual mental and physical activities, highly prevalent in older people, and strongly associated to negative health-related events. The understanding of fatigue is hampered by several issues, including the difficulty at objectively operationalizing, the controversial estimates of its prevalence, and the complex pathophysiological mechanisms underlying its manifestation. Despite such barriers, the study of fatigue is important and might be encouraged. Fatigue may be the marker of the depletion of the body's homeostatic reserves to a threshold leading to its psycho-physical functional impairment, mirroring the concept of frailty. Its subjective and symptomatic nature resembles that of other conditions (e.g., pain, depression), which equally affect the individual's quality of life, expose to negative outcomes, and severely burden healthcare expenditures. In the present paper, we present an overview of the current knowledge on fatigue in older persons in order to increase awareness about its clinical and research relevance. Future research on this topic should be encouraged and developed because it could potentially lead to novel interventions against this symptom as well as against frailty and age-related conditions. Copyright © 2015. Published by Elsevier Inc.
    Experimental Gerontology 07/2015; 70. DOI:10.1016/j.exger.2015.07.011 · 3.49 Impact Factor
  • Source
    • "Chronic pain is related to an increased risk for depressive mood and anxiety disorders (Gerrits et al., 2012). According to a systematic review, 52% of pain patients presented with major depression (Bair et al., 2003). Furthermore, people that present with multiple pain symptoms are 3 to 5 times more likely to be depressed than Fig. 2. Pain-induced by crush neuropathic pain model. "
    [Show abstract] [Hide abstract]
    ABSTRACT: It has been shown that chronic pain is able to induce depressive disorders in humans, in part, due to peripheral inflammation that reaches the central nervous system. However, the mechanisms involved remain to be established. The purpose of this study was to investigate whether sciatic nerve crush could produce depression-like behaviors, in addition to pain-related behaviors, in mice. Once confirmed, this model was used to investigate tumor necrosis factor-α (TNF-α) as a key mediator involved in the pathophysiology of both pain and depression. Experimental approach] Male Swiss mice were divided into 3 groups, naïve, sham and operated. In the operated group, the sciatic nerve was crushed. Following surgery, animals from the operated group were treated daily by oral gavage (p.o.) with saline (10 ml/kg), fluoxetine (20 mg/kg) or thalidomide (10 mg/kg) for 15 days. Mechanical hyperalgesia was evaluated every 3 days by von Frey filaments and depressive-like behavior was assessed at the end of day 15, using the tail suspension test (TST) and the forced swimming test (FST). Then, samples from the prefrontal cortex, hippocampus and sciatic nerve were processed to measure TNF-α levels by ELISA. Crush caused significant mechanical hyperalgesia and depressive-like behaviors and increased TNF-α levels in the sciatic nerve, prefrontal cortex and hippocampus of operated animals. Treatment with fluoxetine or thalidomide reversed crush-induced mechanical hyperalgesia, depressive-like behaviors and the increased TNF-α levels in sciatic nerve, prefrontal cortex and hippocampus. The sciatic nerve crush model represents a good model to study to mechanisms underlying both pain and depressive-like behaviors. Furthermore, inhibitors of TNF-α synthesis, like thalidomide, have a potential to treat depressive disorders associated with neuropathic pain. Copyright © 2015. Published by Elsevier Ltd.
    Neuroscience 06/2015; 303. DOI:10.1016/j.neuroscience.2015.06.044 · 3.36 Impact Factor
  • Source
    • "Pain is known to be one of the strongest predictors of poor quality of life [33], with as many as 27% of chronic pain patients experiencing high levels of disability [8]. Approximately 1 in 2 chronic pain patients meet diagnostic criteria for depression each year [6], and chronic pain is associated with greater risk of suicide [34]. There is substantial research indicating that cognitive-behaviour therapy (CBT) programs result in small but significant reductions in disability, anxiety, and depression associated with chronic pain [17]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The present study evaluated an internet-delivered pain management program, the Pain Course, when provided with different levels of clinician support. Participants (n = 490) were randomised to one of four groups: (1) Regular Contact (n = 143), (2) Optional Contact (n = 141), (3) No Contact (n = 131), and (4) a treatment-as-usual Waitlist-Control Group (n = 75). The treatment program was based on the principles of cognitive behaviour therapy (CBT) and comprised 5 internet-delivered lessons provided over 8 weeks. The three Treatment Groups reported significant improvements (between-groups Cohen's d; avg. reduction) in disability (ds ≥ 0.50; avg. reduction ≥ 18%), anxiety (ds ≥ .44; avg. reduction ≥ 32%), depression (ds ≥ 0.73; avg. reduction ≥ 36%) and average pain (ds ≥ 0.30; avg. reduction ≥ 12%) immediately post-treatment, which were sustained at or further improved to 3-month follow-up. High treatment completion rates and levels of satisfaction were reported and no marked or consistent differences were observed between the Treatment Groups. The mean clinician time per participant was 67.69 minutes (SD = 33.50), 12.85 minutes (SD = 24.61) and 5.44 minutes (SD = 12.38) for those receiving regular contact, the option of contact and no clinical contact, respectively. These results highlight the very significant public health potential of carefully designed and administered internet-delivered pain management programs and indicate that these programs can be successfully administered with several levels of clinical support.This is an open access article distributed under the terms of the Creative Commons Attribution-Noncommercial No Derivatives 3.0 License, which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.
    Pain 05/2015; DOI:10.1097/j.pain.0000000000000251 · 5.21 Impact Factor
Show more